+ Filter
Loading...
EGFR & IGF-1R
Loading...Anti-EGFR & IGF-1R Products
-
- Derivation: Chimeric (mouse/human)
- Species Reactivity: Human
- Type: IgG1 - kappa
- Application: IF, IP, Neut, FuncS, ELISA, FC, ICC
-
- Derivation: Chimeric
- Species Reactivity: Human
- Type: IgG1 - kappa
- Application: FuncS, IF, Neut, ELISA, FC, IP, IHC
-
- Derivation: Human
- Species Reactivity: Human
- Type: IgG1 - kappa
- Application: FC, IP, ELISA, Neut, FuncS, IF, WB
-
- Derivation: Human
- Species Reactivity: Human
- Type: IgG2 - kappa
- Application: ELISA, IP, FC, FuncS, Neut, IF, ICC
-
- Derivation: Humanized (from mouse)
- Species Reactivity: Human
- Type: IgG1 - kappa
- Application: ELISA, IP, FC, FuncS, Neut, IF, IHC
-
- Derivation: Humanized (from rat)
- Species Reactivity: Human
- Type: IgG1 - kappa
- Application: Neut, ELISA, IF, IP, FuncS, FC, WB
-
- Species Reactivity: Human
- Type: Mouse IgG
- Application: ELISA, WB
- Mouse Anti-EGFR Recombinant Antibody (TAB-271MZ) (TAB-271MZ)
-
- Species Reactivity: Human
- Type: Mouse IgG2b
- Application: FuncS
- Mouse Anti-EGFR Recombinant Antibody (TAB-326MZ) (TAB-326MZ)
-
- Species Reactivity: Human
- Type: Mouse IgG
- Application: FC
- Anti-Human EGFR Recombinant Antibody (ABT-806) (TAB-228CL)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Antibody
- Application: WB, IHC
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: ADCC enhanced antibody
-
- Derivation: Human
- Species Reactivity: Human
- Type: IgG1 - kappa
- Application: ELISA, FC, IP, FuncS, IF, Neut, ICC
-
- Derivation: Chimeric (human/mouse)
- Species Reactivity: Human
- Type: IgG1 - kappa
- Application: IF, WB, Inhib
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: IgG1
- Application: Neut, ELISA, IF, IP, FuncS, FC, ICC
-
- Derivation: Chimeric (Human/Mouse)
- Species Reactivity: Human
- Type: IgG1 - kappa
- Application: Neut, ELISA, IF, IP, FuncS, FC, WB
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse IgG1, κ
- Application: WB, ELISA, FC, IF, IHC, FuncS
-
- Species Reactivity: Human
- Type: Human IgG
- Application: ELISA, WB, FuncS
- Human Anti-EGFR Recombinant Antibody; scFv Fragment (TAB-270MZ-S(P)) (TAB-270MZ-S(P))
-
- Species Reactivity: Human
- Type: Human scFv
- Application: ELISA
- Human Anti-EGFR Recombinant Antibody (TAB-0225CL) (TAB-0225CL)
-
- Derivation: Chimeric (Mouse/Human)
- Species Reactivity: Human
- Type: Chimeric (Mouse/Human) IgG1
- Application: Block, Inhib, FuncS, Apop, In vivo
- Human Anti-EGFR Recombinant Antibody (TAB-270MZ) (TAB-270MZ)
-
- Species Reactivity: Human
- Type: Human antibody
- Application: ELISA
- Anti-Human EGFR Recombinant Antibody (EG-19-11) (TAB-313MZ)
-
- Derivation: Library
- Type: Human antibody
- Application: ELISA, FC
- Anti-Human EGFR Recombinant Antibody (DX 1-4) (TAB-321MZ)
-
- Type: Human antibody
- Application: SPR
- Anti-Human EGFR Recombinant Antibody (DX 1-6) (TAB-322MZ)
-
- Type: Human antibody
- Application: SPR
- Anti-Human EGFR Recombinant Antibody (DX 1-10) (TAB-323MZ)
-
- Type: Human antibody
- Application: SPR
- Anti-Human EGFR Recombinant Antibody (pSEX81-6) (TAB-324MZ)
-
- Derivation: Phage display library
- Type: Human antibody
- Application: IP, ELISA, FC
- Anti-Human EGFR Recombinant Antibody (pSEX81-63) (TAB-325MZ)
-
- Derivation: Phage display library
- Type: Human antibody
- Application: IP, ELISA, FC
- Human Anti-EGFR Recombinant Antibody; scFv Fragment (TAB-274MZ-S(P)) (TAB-274MZ-S(P))
-
- Species Reactivity: Human
- Type: Humanized scFv
- Application: FC
- Mouse Anti-EGFR Recombinant Antibody; scFv Fragment (TAB-272MZ-S(P)) (TAB-272MZ-S(P))
-
- Species Reactivity: Human
- Type: Mouse scFv
- Application: FuncS
- Human Anti-EGFR Recombinant Antibody; scFv Fragment (TAB-278MZ-S(P)) (TAB-278MZ-S(P))
-
- Species Reactivity: Human
- Type: Human scFv
- Application: ELISA, WB
- Human Anti-EGFR Recombinant Antibody; scFv Fragment (TAB-279MZ-S(P)) (TAB-279MZ-S(P))
-
- Species Reactivity: Human
- Type: Human scFv
- Application: ELISA, WB
- Anti-Human EGFR Recombinant Antibody (EG-26-11) (TAB-314MZ)
-
- Derivation: Library
- Type: Human antibody
- Application: ELISA
- Human Anti-EGFR Recombinant Antibody (TAB-272MZ) (TAB-272MZ)
-
- Species Reactivity: Human
- Type: Chimeric (mouse/human) IgG
- Application: FuncS
-
- Species Reactivity: Human
- Type: Mouse IgG
- Application: FC
-
- Derivation: Chimeric (mouse/human)
- Species Reactivity: Human
- Type: Chimeric (mouse/human) IgG
- Application: FuncS
-
- Species Reactivity: Human
- Type: Mouse scFv
- Application: ELISA, WB
-
- Species Reactivity: Human
- Type: Human IgG
- Application: FC
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized IgG
- Application: ELISA, WB, FuncS
-
- Species Reactivity: Human
- Type: Mouse IgG
- Application: WB
- Rabbit Anti-Human EGFR (phospho Y1092) Antibody (MOB-0242MC)
-
- Species Reactivity: Rat, Human
- Application: IHC, WB
- Rabbit Anti-Human EGFR (phospho Y1068) Antibody (MOB-0243MC)
-
- Species Reactivity: Human, Mouse, Rat
- Application: IHC, WB
- Anti-Human EGFR Recombinant Antibody (528) (TAB-315MZ)
-
- Type: Human antibody
- Application: Inhib
- Human Anti-EGFR Recombinant Antibody (TAB-274MZ) (TAB-274MZ)
-
- Species Reactivity: Human
- Type: Humanized IgG
- Application: FC
- Human Anti-EGFR Recombinant Antibody (TAB-282MZ) (TAB-282MZ)
-
- Species Reactivity: Human
- Type: Human IgG
- Application: Cyt, FuncS, Inhib
- Human Anti-EGFR Recombinant Antibody (TAB-283MZ) (TAB-283MZ)
-
- Species Reactivity: Human
- Type: Human IgG
- Application: Cyt, FuncS, Inhib
- Human Anti-EGFR Recombinant Antibody (TAB-284MZ) (TAB-284MZ)
-
- Species Reactivity: Human
- Type: Human IgG
- Application: ELISA
- Human Anti-EGFR Recombinant Antibody (TAB-287MZ) (TAB-287MZ)
-
- Species Reactivity: Human
- Type: Human IgG1
- Application: ADCC assay
- Human Anti-EGFR Recombinant Antibody (TAB-288MZ) (TAB-288MZ)
-
- Species Reactivity: Human
- Type: Human IgG1
- Application: ADCC assay
- Human Anti-EGFR Recombinant Antibody (TAB-289MZ) (TAB-289MZ)
-
- Species Reactivity: Human
- Type: Human IgG1
- Application: ADCC assay
- Human Anti-EGFR Recombinant Antibody (TAB-278MZ) (TAB-278MZ)
-
- Species Reactivity: Human
- Type: Human IgG
- Application: Cyt, ELISA, Inhib
- Human Anti-EGFR Recombinant Antibody (TAB-279MZ) (TAB-279MZ)
-
- Species Reactivity: Human
- Type: Human IgG
- Application: Cyt, ELISA, Inhib
- Human Anti-EGFR Recombinant Antibody; Fab Fragment (TAB-270MZ-F(E)) (TAB-270MZ-F(E))
-
- Species Reactivity: Human
- Type: Human Fab
- Application: ELISA
- Mouse Anti-EGFR Recombinant Antibody; Fab Fragment (TAB-271MZ-F(E)) (TAB-271MZ-F(E))
-
- Species Reactivity: Human
- Type: Mouse Fab
- Application: FuncS
- Mouse Anti-EGFR Recombinant Antibody (TAB-281MZ) (TAB-281MZ)
-
- Species Reactivity: Human
- Type: Mouse IgG
- Application: WB, IF, IHC
- Mouse Anti-EGFR Recombinant Antibody; Fab Fragment (TAB-0564CL-F(E)) (TAB-0564CL-F(E))
-
- Species Reactivity: Human
- Type: Mouse Fab
- Application: ELISA
- Mouse Anti-EGFR Recombinant Antibody; Fab Fragment (TAB-0565CL-F(E)) (TAB-0565CL-F(E))
-
- Species Reactivity: Human
- Type: Mouse Fab
- Application: ELISA
- Mouse Anti-EGFR Recombinant Antibody (TAB-285MZ) (TAB-285MZ)
-
- Species Reactivity: Human
- Type: Mouse IgG
- Application: FuncS
- Mouse Anti-EGFR Recombinant Antibody (TAB-286MZ) (TAB-286MZ)
-
- Species Reactivity: Human
- Type: Mouse IgG
- Application: FuncS
- Mouse Anti-EGFR Recombinant Antibody (TAB-275MZ) (TAB-275MZ)
-
- Species Reactivity: Human
- Type: Mouse IgG
- Application: Cyt, FuncS, Inhib
- Anti-Human EGFR Recombinant Antibody (LA1) (TAB-276MZ)
-
- Application: Cyt, FuncS
- Anti-Human EGFR Recombinant Antibody (LA22) (TAB-277MZ)
-
- Application: Cyt, FuncS
-
- Derivation: Llama
- Species Reactivity: Human
- Type: Llama VHH
- Application: FuncS, SPR
-
- Species Reactivity: Human
- Type: Human Fab
- Application: FC
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized Fab
- Application: ELISA, WB, FuncS
-
- Species Reactivity: Human
- Type: Mouse Fab
- Application: WB
-
- Species Reactivity: Human
- Type: Human scFv
- Application: FC
- Anti-Human EGFR Recombinant Antibody (07D06) (TAB-316MZ)
-
- Application: FuncS, Inhib
- Anti-Human EGFR Recombinant Antibody (12D03) (TAB-317MZ)
-
- Application: FuncS, Inhib
- Mouse Anti-EGFR Recombinant Antibody (TAB-273MZ) (TAB-273MZ)
-
- Species Reactivity: Human
- Type: Mouse IgG
- Application: FC, FuncS, IHC, IP, Inhib
- Mouse Anti-EGFR Recombinant Antibody; scFv Fragment (TAB-273MZ-S(P)) (TAB-273MZ-S(P))
-
- Species Reactivity: Human
- Type: Mouse scFv
- Application: FC
- Mouse Anti-EGFR Recombinant Antibody; scFv Fragment (TAB-275MZ-S(P)) (TAB-275MZ-S(P))
-
- Species Reactivity: Human
- Type: Mouse scFv
- Application: FC
- Anti-Human EGFR Recombinant Antibody scFv Fragment (LA1) (TAB-276MZ-S(P))
-
- Application: MTT assay
- Anti-Human EGFR Recombinant Antibody scFv Fragment (LA22) (TAB-277MZ-S(P))
-
- Application: MTT assay
- Mouse Anti-EGFR Recombinant Antibody; scFv Fragment (TAB-271MZ-S(P)) (TAB-271MZ-S(P))
-
- Species Reactivity: Human
- Type: Mouse scFv
- Application: FuncS
-
- Species Reactivity: Human
- Type: Human Fab
- Application: ELISA, WB, FuncS
-
- Derivation: Llama
- Species Reactivity: Human
- Type: Llama VHH
- Application: WB, ELISA
-
- Derivation: Llama
- Species Reactivity: Human
- Type: Llama VHH
- Application: FuncS, ELISA, IF
- 10-FnIII scaffold protein anti-Human EGFR (SFN-L003)
-
- Scaffold Name: 10-FnIII
- Target: EGFR
- Species Reactivity: Human
- Derivation: Phage display
-
- Scaffold Name: Z-domain of protein A
- Target: EGFR
- Species Reactivity: Human
- Derivation: Phage display
- Anti-EGFR Antibody-Cytokine Fusion Protein, IgG-IL2 (ACFP-SH155)
-
- Target: EGFR
- Species Reactivity: Human
- Cytokine 1: IL2
- Host: Humanized from Mouse
- Cytokine 1 Species: Human
- Molecule Class: IgG1-IL2
-
- Species Reactivity: Mouse
- Type: Llama VHH
- Application: ELISA, IHC, FC, FuncS
- Anti-EGFR (J2898A)-SMCC-DM1 ADC (IMGN289) (ADC-L016)
-
- Target: EGFR
- Linker: SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto- 1-oxopropyl)maytansine)
- Anti-EGFR-MC-VC-PABA-MMAE ADC (ADC-037CL)
-
- Target: EGFR
- Linker: MC-VC-PABC (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl)
- Drug: MMAE (Monomethyl auristatin E)
- Anti-EGFR-MC-VC-PABA-MMAE ADC (ADC-038CL)
-
- Target: EGFR
- Linker: MC-VC-PABC (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl)
- Drug: MMAE (Monomethyl auristatin E)
- Anti-EGFR-mc-MMAF ADC (ADC-039CL)
-
- Target: EGFR
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)
- Anti-EGFR (clone Antibody 1)-MC-MMAF ADC (ADC-059CL)
-
- Target: EGFR
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)
- Anti-EGFR (clone Bat0206)-S-3AA-MDC ADC (ADC-157CL)
-
- Target: EGFR
- Linker: S-3AA
- Drug: MDC (maytansinol)
- Anti-EGFR (clone Bat0206)-SMCC-MDC ADC (ADC-158CL)
-
- Target: EGFR
- Linker: SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate)
- Drug: MDC (maytansinol)
- Anti-EGFR-vc-PAB-MODO ADC (ADC-263CL)
-
- Target: epidermal growth factor receptor (EGFR)
- Linker: VC-PAB (valine-citrulline-p-aminobenzoyloxycarbonyl)
- Drug: MODO (monomethyldolastatin)
- Anti-EGFR-Mal-dPEG4-NHS-DM1 ADC (ADC-107LCT)
-
- Target: EGFR
- Linker: Mal-dPEG4-NHS
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
- Anti-EGFR (MAb806)-Mc-MMAF ADC (ADC-109LCT)
-
- Target: EGFR
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)
- Anti-EGFR (MAb806)-SMCC-DM1 ADC (ADC-110LCT)
-
- Target: EGFR variant III
- Linker: SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
- Anti-EGFR (clone J2898A)-SMCC-DM1 ADC (ADC-047LZY)
-
- Target: EGFR
- Linker: SMCC (N-succinimidyl-4-(N-maleimidomethyl)-cyclohexane-1-carboxylate)
- Drug: DM1(N2'-deacetyl-N2'-(3-mercapto-1-oxopropyl)-maytansine)
- Anti-EGFR-vc-Duostatin-3 ADC (ADC-088LZY)
-
- Target: EGFR
- Linker: VC (valine-citrulline)
- Drug: Duostatin-3
- Anti-EGFRvIII-SMCC-DM1 ADC (ADC-048LZY)
-
- Target: EGFRvIII
- Linker: SMCC (N-succinimidyl-4-(N-maleimidomethyl)-cyclohexane-1-carboxylate)
- Drug: DM1(N2'-deacetyl-N2'-(3-mercapto-1-oxopropyl)-maytansine)
- Anti-EGFR-doxorubicin ADC (ADC-168LZY)
-
- Target: EGFR
- Linker: polyethylene glycol linker
- Drug: doxorubicin
- Anti-EGFR-MCC-Dox ADC (ADC-057LZY)
-
- Target: EGFR
- Linker: MCC (4-(N-maleimidomethyl)cyclohexane-1-carboxylate)
- Drug: doxorubicin
- Anti-EGFR-EDC/NHS-Dox ADC (ADC-058LZY)
-
- Target: EGFR
- Linker: EDC/NHS(1-ethyl-3-(3-diaminopropyl)carbodiimide/N-hydroxysuccinimide)
- Drug: doxorubicin
- Anti-EGFR-SMCC-methotrexate ADC (ADC-059LZY)
-
- Target: EGFR
- Linker: SMCC (N-succinimidyl-4-(N-maleimidomethyl)-cyclohexane-1-carboxylate)
- Drug: MTX
- Anti-EGFR-EDC/NHS-methotrexate ADC (ADC-060LZY)
-
- Target: EGFR
- Linker: EDC/NHS
- Drug: MTX
- Anti-EGFR (ABT-806)-Mc-MMAE ADC (ABT-414) (ADC-L001)
-
- Target: EGFR
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)
View More Products
Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag
More Infomation
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
For Research Use Only. Not For Clinical Use.
Background
This receptor binds insulin-like growth factor with a high affinity. It has tyrosine kinase activity. The insulin-like growth factor I receptor plays a critical role in transformation events. Cleavage of the precursor generates alpha and beta subunits. It is highly overexpressed in most malignant tissues where it functions as an anti-apoptotic agent by enhancing cell survival. Alternatively spliced transcript variants encoding distinct isoforms have been found for this gene.
Receptor for EGF, but also for other members of the EGF family, as TGF-alpha, amphiregulin, betacellulin, heparin-binding EGF-like growth factor, GP30 and vaccinia virus growth factor. Is involved in the control of cell growth and differentiation. Phosphorylates MUC1 in breast cancer cells and increases the interaction of MUC1 with SRC and CTNNB1/beta-catenin. Isoform 2 may act as an antagonist of EGF action.


Bladder Cancer
Non-small Cell Lung Cancer
Pancreatic Cancer
Hepatocellular Carcinoma
Cushing Syndrome
JAK-STAT Signaling Pathway
